YOKOHAMA, Japan & AARHUS, Denmark– RIKEN and CLC bio Japan announced an agreement for the purchase of CLC bio’s enterprise platform software by RIKEN Omics Science Center (OSC). CLC bio’s high-throughput sequence analysis infrastructure will empower both OSC’s scientists and OSC’s Genome Network Analysis Service (GeNAS) with a user-friendly and fast workflow to efficiently manage and analyze large quantities of genomics data.

“This agreement accentuates the importance of the Japanese market to CLC bio. To stress our commitment to our operations in Japan, we’re already planning further expansions of CLC bio Japan!”

RIKEN OSC Facility Director, Dr. Carsten O. Daub, states, “It is customary for us to develop our own in-house software that is tailor-made to our very specialized needs. However, we were very impressed with the performance and flexibility of CLC bio’s software for a wide range of high-throughput sequence analysis projects and decided that it would be faster and more efficient for us to adopt their enterprise platform.”

CEO at CLC bio Japan, David Leangen, continues, “Having such an advanced and world renowned research center choose our enterprise platform emphasizes CLC bio as the global leader in high-throughput sequencing analysis solutions. Furthermore, it establishes CLC bio Japan as the major solution provider in the Japanese sequence analysis market.”

CEO at CLC bio, Thomas Knudsen, adds, “This agreement accentuates the importance of the Japanese market to CLC bio. To stress our commitment to our operations in Japan, we’re already planning further expansions of CLC bio Japan!”

About RIKEN Omics Science Center

RIKEN is a Japanese research institute that carries out high-level experimental and research work in a wide range of fields, including physics, chemistry, medical science, biology, and engineering, covering the entire range from basic research to practical applications. RIKEN was first organized in 1917 as a private research foundation and was reorganized in 2003 as an independent administrative institution under the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. RIKEN Omics Science Center (OSC) is one of 13 research centers in RIKEN and its focus is on the development of genome-wide technologies and their applications. RIKEN OSC has been working as the sequencing center of the “Cell Innovation Project” of the MEXT since April 2009.

http://www.osc.riken.jp/english/

About CLC bio Japan

CLC bio Japan is a subsidiary of CLC bio, established in 2009 with the aim of servicing the Japanese market.

http://www.clcbio.co.jp

About CLC bio

http://www.clcbio.com/about